Making rational choices to improve neoadjuvant chemoradiation for rectal cancer - The Patel/Puthillath/Yang et al article reviewed [Neoadjuvant chemoradiation fr rectal cancer: Is more better?] Journal Article

  


Authors: Goodman, K. A.; Thomas, C. R. Jr
Article Title: Making rational choices to improve neoadjuvant chemoradiation for rectal cancer - The Patel/Puthillath/Yang et al article reviewed [Neoadjuvant chemoradiation fr rectal cancer: Is more better?]
Keywords: cancer survival; gene mutation; clinical trial; bevacizumab; cytotoxic agent; fluorouracil; cancer risk; note; cancer radiotherapy; radiation dose; cancer staging; positron emission tomography; heart disease; combination chemotherapy; hodgkin disease; nonhodgkin lymphoma; cardiovascular disease; cardiovascular risk; folinic acid; adjuvant chemotherapy; thrombosis; fluorodeoxyglucose f 18; oncogene k ras; oxaliplatin; esophagus cancer; rectum cancer; rectum surgery; epidermal growth factor receptor kinase inhibitor
Journal Title: Oncology (Norwalk)
Volume: 22
Issue: 7
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 2008-06-01
Start Page: 830
End Page: 831, 836
Language: English
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-47549118681&partnerID=40&md5=142b37185e0fab8647c85fc5ef9570e2
Notes: --- - "Export Date: 17 November 2011" - "CODEN: OCLGE" - "Source: Scopus"